Имунайн

Имунайн is a human coagulation factor IX used to manage bleeding in hemophilia B. This intravenous therapy supports blood clotting processes. Suitable for patients with factor IX deficiency. Supports hemostasis in bleeding episodes.

Имунайн is used to control and prevent bleeding episodes in patients with hemophilia B, a condition caused by a deficiency in coagulation factor IX. It is also administered to support perioperative hemostasis in patients undergoing surgery. This therapy helps restore normal clotting function when the body’s natural factor IX levels are insufficient. It is not indicated for other types of hemophilia or bleeding disorders.

When administered, Имунайн helps the blood to clot more effectively by replacing the missing or deficient factor IX. Patients may experience improved control of bleeding episodes following treatment. The duration of effect depends on individual response and dosing. Regular use may help maintain stable clotting function over time.

Имунайн should be handled and administered by healthcare professionals experienced in treating bleeding disorders. Patients should be monitored for signs of allergic reactions or infusion-related issues during administration. Proper storage conditions must be maintained to preserve the product’s efficacy. Always follow medical guidance for use and handling.

No specific drug interactions have been established for Имунайн. However, as with any intravenous therapy, caution is advised when used with other medications that may affect blood clotting. Patients should inform their healthcare provider about all medications they are taking. Avoid mixing with other products unless approved by a medical professional.